Atwater Malick’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11.4M Buy
165,605
+1,736
+1% +$120K 3.62% 11
2025
Q1
$11.4M Buy
163,869
+1,641
+1% +$114K 3.85% 10
2024
Q4
$14M Sell
162,228
-4,604
-3% -$396K 4.68% 7
2024
Q3
$19.9M Sell
166,832
-1,668
-1% -$199K 6.39% 2
2024
Q2
$24.1M Sell
168,500
-144
-0.1% -$20.6K 8.29% 1
2024
Q1
$21.7M Sell
168,644
-1,634
-1% -$210K 7.63% 1
2023
Q4
$17.6M Sell
170,278
-2,314
-1% -$239K 6.9% 2
2023
Q3
$15.7M Sell
172,592
-2,760
-2% -$251K 6.91% 2
2023
Q2
$14.2M Buy
175,352
+70
+0% +$5.66K 6.06% 2
2023
Q1
$13.9M Sell
175,282
-3,270
-2% -$260K 6.54% 2
2022
Q4
$12.1M Sell
178,552
-538
-0.3% -$36.4K 5.95% 2
2022
Q3
$8.92M Buy
179,090
+1,396
+0.8% +$69.5K 4.98% 3
2022
Q2
$9.9M Buy
177,694
+1,410
+0.8% +$78.6K 5.21% 2
2022
Q1
$9.79M Buy
176,284
+4,888
+3% +$271K 4.73% 4
2021
Q4
$9.6M Sell
171,396
-1,652
-1% -$92.5K 4.46% 5
2021
Q3
$8.31M Buy
173,048
+2,134
+1% +$102K 4.39% 5
2021
Q2
$7.16M Buy
170,914
+7,912
+5% +$331K 3.96% 9
2021
Q1
$5.5M Sell
163,002
-7,256
-4% -$245K 3.37% 14
2020
Q4
$5.95M Buy
170,258
+2,762
+2% +$96.5K 3.74% 11
2020
Q3
$5.82M Buy
167,496
+3,434
+2% +$119K 4.07% 8
2020
Q2
$5.37M Buy
164,062
+2,670
+2% +$87.4K 4.23% 7
2020
Q1
$4.86M Buy
161,392
+2,694
+2% +$81.1K 4.66% 7
2019
Q4
$4.59M Buy
158,698
+5,854
+4% +$169K 3.65% 15
2019
Q3
$3.95M Buy
152,844
+7,508
+5% +$194K 3.32% 18
2019
Q2
$3.71M Buy
145,336
+6,102
+4% +$156K 3.4% 18
2019
Q1
$3.64M Buy
139,234
+5,418
+4% +$142K 3.56% 17
2018
Q4
$3.08M Buy
+133,816
New +$3.08M 3.45% 16